Supplementary Table 1.Mean and SEM for number of anogenital investigations
Trial 1 / Trial 2 / Trial 3Genotype / Resident Sex / Male Intruder / Female Intruder / Male Intruder / Female Intruder / Male Intruder / Female Intruder
WT / Male / 14.38 (2.86) / 24.13 (2.05) / 16.38 (2.77) / 21.00 (12.12) / 15.00 (2.61) / 22.88 (3.52)
Female / 17.83 (3.19) / 27.17 (2.37) / 19.00 (3.20) / 25.33 (13.99) / 18.17 (3.01) / 28.17 (4.06)
Nes-AR / Male / 21.00 (3.29) / 21.00 (2.37) / 20.00 (3.19) / 30.17 (13.99) / 17.67 (3.01) / 27.83 (4.02)
Female / 22.25 (4.04) / 17.25 (2.89) / 19.75 (3.92) / 16.00 (17.14) / 20.50 (3.68) / 17.25 (4.98)
CMV-AR / Male / 20.67 (3.29) / 25.83 (2.37) / 17.50 (3.19) / 53.40 (13.99) / 25.67 (3.01) / 24.50 (4.06)
Female / 23.43 (3.05) / 22.00 (2.19) / 22.57 (2.96) / 26.71 (12.96) / 23.86 (2.79) / 30.71 (3.76)
Supplementary Table 2: Mean and SEM for anogenital investigation duration
Trial 1 / Trial 2 / Trial 3Genotype / Resident Sex / Male Intruder / Female Intruder / Male Intruder / Female Intruder / Male Intruder / Female Intruder
WT / Male / 112.34 (37.44) / 232.65 (30.58) / 123.71 (33.79) / 116.77 (23.92) / 94.89 (32.17) / 125.11 (42.13)
Female / 230.25 (43.23) / 275.15 (35.31) / 194.45 (39.02) / 200.79 (27.60) / 225.74 (37.15) / 241.70 (48.70)
Nes-AR / Male / 164.97 (43.23) / 266.15 (35.31) / 139.59 (39.02) / 213.18 (27.62) / 95.69 (37.15) / 148.69 (48.65)
Female / 269.95 (52.95) / 139.78 (43.25) / 182.05 (47.79) / 119.58 (33.82) / 160.52 (45.49) / 270.85 (59.58)
CMV-AR / Male / 211.65 (43.23) / 226.30 (35.31) / 136.59 (39.02) / 143.32 (27.62) / 200.26 (37.15) / 190.15 (48.65)
Female / 338.77 (40.02) / 221.29 (32.69) / 286.47 (36.13) / 208.93 (25.57) / 282.87 (34.39) / 238.25 (45.04)
Supplementary Table 3.Mean and SEM of the number of Face investigations
Trial 1 / Trial 2 / Trial 3Genotype / Resident Sex / Male Intruder / Female Intruder / Male Intruder / Female Intruder / Male Intruder / Female Intruder
WT / Male / 9.17 (2.77) / 4.00 (2.19) / 6.33 (2.38) / 4.33 (2.62) / 6.17 (2.22) / 2.83 (2.63)
Female / 7.83 (2.77) / 7.67 (2.19) / 12.17 (2.37) / 11.67 (3.62) / 7.33 (2.23) / 6.33 (2.62)
Nes-AR / Male / 18.67 (3.92) / 5.67 (3.11) / 12.00 (3.36) / 11.00 (3.15) / 11.00 (3.15) / 13.67 (3.72)
Female / 11.50 (3.39) / 3.75 (2.69) / 12.00 (2.91) / 9.50 (4.43) / 8.25 (2.73) / 6.50 (3.32)
CMV-AR / Male / 16.17 (2.77) / 8.50 (2.20) / 5.00 (2.38) / 15.72 (3.62) / 11.17 (2.23) / 8.5 (2.63)
Female / 7.86 (2.57) / 6.57 (2.03) / 12.14 (2.20) / 12.71 (3.35) / 8.86 (2.06) / 7.00 (2.43)
Supplementary Table 4.Duration of face investigation
Trial 1 / Trial 2 / Trial 3Genotype / Resident Sex / Male Intruder / Female Intruder / Male Intruder / Female Intruder / Male Intruder / Female Intruder
WT / Male / 35.07 (19.61) / 9.92 (13.14) / 49.17 (34.06) / 11.13 (21.21) / 30.73 (19.92) / 5.86 (11.79)
Female / 57.13 (19.61) / 23.75 (13.14) / 69.95 (34.06) / 59.20 (21.22) / 32.15 (19.92) / 21.61 (11.79)
Nes-AR / Male / 92.90 (27.73) / 22.90 (18.58) / 63.34 (48.17) / 35.64 (30.01) / 43.13 (28.27) / 45.77 (16.69)
Female / 43.98 (24.02) / 9.25 (16.09) / 82.59 (41.72) / 25.40 (25.98) / 29.54 (24.40) / 27.82 (14.45)
CMV-AR / Male / 86.65 (19.61) / 47.22 (13.14) / 94.82 (34.06) / 51.87 (21.22) / 60.58 (19.92) / 34.71 (11.79)
Female / 24.59 (18.15) / 16.69 (12.17) / 76.29 (31.54) / 40.26 (19.65) / 48.81 (18.44) / 19.31 (10.92)
Supplementary Table 5.Mean and SEM of the number of chasing bouts
Trial 1 / Trial 2 / Trial 3Genotype / Resident Sex / Male Intruder / Female Intruder / Male Intruder / Female Intruder / Male Intruder / Female Intruder
WT / Male / 6.38 (1.60) / 0.25 (0.29) / 4.50 (1.61) / 0.88 (0.27) / 8.13 (2.35) / 0.38 (0.23)
Female / 3.33 (1.85) / 0.67 (0.34) / 0 / 0.167 (0.32) / 1.00 (2.71) / 0
Nes-AR / Male / 0.17 (1.85) / 0.50 (0.34) / 3.50 (1.86) / 0.17 (0.32) / 5.17 (2.71) / 0.50 (0.27)
Female / 0.25 (2.27) / 0.25 (0.41) / 0.25 (2.28) / 0.50 (0.39) / <.01 (3.32) / 0.25 (0.33)
CMV-AR / Male / 1.17 (1.85) / 0 / 0 / 0 / 2.00 (2.71) / 0.50 (0.27)
Female / 0.43 (1.71) / 0 / 0 / 0.14 (.29) / 0.57 (2.51) / 0
Supplementary Table 6.Mean and SEM of the duration of chasing
Trial 1 / Trial 2 / Trial 3Genotype / Resident Sex / Male Intruder / Female Intruder / Male Intruder / Female Intruder / Male Intruder / Female Intruder
WT / Male / 11.71 (3.06) / 0.19 (0.32) / 12.11 (4.17) / 0.58 (0.23) / 17.92 (6.23) / 0.36 (0.73)
Female / 5.70 (3.54) / 0.58 (0.37) / <0.01 (0.12) / 0.12 (0.27) / 3.25 (7.25) / 0
Nes-AR / Male / 0.05 (3.53) / 0.93 (0.37) / 6.07 (4.81) / 0.13 (0.27) / 15.35 (7.30) / 0.53 (0.85)
Female / 0.23 (4.33) / 0.28 (0.45) / 0.33 (5.89) / 0.61 (0.33) / 0 / 2.79 (1.04)
CMV-AR / Male / 2.17 (3.50) / < 0.01 (0.36) / 3.47 (7.25) / 0 / 3.47 (7.25) / 1.19 (0.84)
Female / 11.71 (3.06) / 0.19 (0.32) / 12.11 (4.17) / 0.58 (0.23) / 17.92 (6.23) / 0.36 (0.73)
Supplementary Table 7. Mean and SEM of the number of tumbling bouts
Trial 1 / Trial 2 / Trial 3Genotype / Resident Sex / Male Intruder / Female Intruder / Male Intruder / Female Intruder / Male Intruder / Female Intruder
WT / Male / 5.75 (1.58) / 0 / 2.50 (.80) / <.01 (0.17) / 5.63 (1.87) / 0.38 (0.13)
Female / 3.00 (1.83) / 0 / <.01 (0.93) / <.01 (0.20) / 0.17 (2.16) / 0
Nes-AR / Male / 2.17 (1.83) / 0 / 2.17 (0.92) / 0.50 (0.20) / 3.00 (2.17) / <.01 (0.14)
Female / 0 / 0 / <.01 (1.13) / <.01 (0.25) / 0 / 0
CMV-AR / Male / 0.67 (1.83) / 0 / 0 / <.01 (.20) / 2.50 (2.10) / 0
Female / <.01 (1.69) / 0 / 0 / 0 / 0.14 (2.00) / 0
Supplementary Table 8.Mean and SEM of the number of boxing bouts
Trial 1 / Trial 2 / Trial 3Genotype / Resident Sex / Male Intruder / Female Intruder / Male Intruder / Female Intruder / Male Intruder / Female Intruder
WT / Male / 1.88 (0.64) / 0 / 1.25 (0.69) / <0.01 (0.12) / 1.50 (0.97) / 0
Female / 1.00 (0.73) / 0 / 0 / <0.01 (0.13) / 0.17 (1.12) / 0
Nes-AR / Male / 0.83 (0.74) / 0 / 1.83 (0.79) / 0.33 (0.13) / 4.67 (1.12) / 0
Female / <0.01 (0.90) / 0 / <0.01 (0.98) / <0.01 (0.16) / <0.01 (1.37) / 0
CMV-AR / Male / 0.50 (0.74) / 0 / 0 / <0.01 (0.13) / 0.50 (1.12) / 0
Female / 0 / 0 / 0 / 0 / 0 / 0
Supplementary Table 9.Mean and SEM of the number of thrusts
Trial 1 / Trial 2 / Trial 3Genotype / Resident Sex / Male Intruder / Female Intruder / Male Intruder / Female Intruder / Male Intruder / Female Intruder
WT / Male / 1.75 (1.11) / 12.63 (4.88) / 2.50 (1.72) / 34.63 (13.48) / 0.25 (1.39) / 25.75 (14.82)
Female / 0.83 (1.28) / 4.17 (5.64) / 0 / 28.67 (15.57) / 2.50 (1.61) / 2.33 (17.11)
Nes-AR / Male / 0.17 (1.28) / 1.17 (5.64) / 2.17 (1.98) / 16.50 (15.57) / 1.83 (1.61) / 6.33 (17.11)
Female / 2.25 (1.57) / 8.50 (6.90) / 0.50 (2.43) / 19.00 (19.07) / < 0.01 (1.98) / 0
CMV-AR / Male / 0.33 (1.28) / 5.00 (5.64) / 3.12 (1.99) / 36.67 (15.57) / 3.00 (1.61) / 84.00 (17.11)
Female / 1.70 (1.18) / 11.14 (5.22) / 4.00 (1.84) / 14.00 (14.42) / 1.14 (1.49) / 7.43 (15.84)